Femasys (FEMY) announces the Company has secured strategic distribution partnerships for FemBloc in Spain. Comercial Medico Quirurigca, SA will expand its commercial portfolio to include FemBloc, alongside other Femasys products in northern Spain, while Durgalab will handle distribution in the southern region.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FEMY:
- Femasys Achieves CE Mark for FemBloc, Paving the Way for European Market Entry and Justifying Buy Rating
- Femasys announces FemBloc delivery system approval in Europe
- Femasys’s FemBloc: A Promising Investment in Permanent Contraceptive Innovation
- Femasys announces publication of ‘positive’ results from FemBloc trials
- Femasys announces UK regulatory approvals for FemaSeed
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue